OAR 333-019-0042
Other Disease Specific Provisions: Tuberculosis Screening in Correctional Facilities

(1)

For purposes of this rule:

(a)

“Correctional facility” means a facility operated by the Oregon Department of Corrections or a local correctional facility as that is defined in ORS 169.005 (Definitions for ORS 169.005 to 169.685 and 169.730 to 169.800); and

(b)

“Symptoms of TB disease” means a cough longer than 3 weeks and/or coughing up blood in conjunction with fever, fatigue, night sweats or weight loss.

(2)

A correctional facility shall screen all inmates upon admission for symptoms of tuberculosis (TB) disease. This screening and any follow-up shall be documented.

(3)

Any inmate suspected of having TB disease or who has TB disease shall be isolated as appropriate and provided medical care and treatment that meets accepted standards of practice.

(4)

Inmates detained or confined for 15 consecutive days or more in a correctional facility shall be screened for the following TB risk factors:

(a)

HIV/AIDS;

(b)

Immigration within the past five years from a country that has a high incidence of TB, including but not limited to immigration from Africa, Asia, Middle East, Latin America, Eastern Europe and South Pacific regions;

(c)

Close contact to a person with infectious TB disease;

(d)

History of injection drug use;

(e)

History of homelessness; and

(f)

Taking immunosuppressive medication.

(5)

Inmates screened under section (4) of this rule who have TB risk factors and no documented history of prior positive screening tests for TB shall be screened with either a TB skin test or interferon gamma release assay (IGRA). Inmates with a documented previously positive TB skin test or IGRA, or a new positive result upon testing, shall receive a chest X-ray.

(6)

Exceptions:

(a)

A correctional facility is not required to retest an inmate at each admission under section (5) of this rule if:

(A)

There is a documented record of a negative TB skin test or negative IGRA or normal chest X-ray within the past year; or

(B)

There is a documented record of adequate TB treatment or compliance with a currently prescribed TB treatment.

(b)

This exception does not apply if the inmate has symptoms of TB, evidence of new exposure to a person with infectious TB disease or a diagnosis of HIV/AIDS.

(7)

Nothing in these rules prohibit any correctional facility from having more stringent TB screening requirements.

Source: Rule 333-019-0042 — Other Disease Specific Provisions: Tuberculosis Screening in Correctional Facilities, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=333-019-0042.

333‑019‑0000
Responsibility of Public Health Authorities to Investigate Reportable Diseases 333‑019‑0002
Cooperation with Public Health Authorities 333‑019‑0003
Providing Information to the Oregon Health Authority or Local Public Health Administrator 333‑019‑0005
Conduct of Special Studies by Oregon Health Authority 333‑019‑0010
Disease Related School, Child Care, and Worksite Restrictions: Imposition of Restrictions 333‑019‑0014
Disease Related School, Child Care, and Worksite Restrictions: Removal of Restrictions 333‑019‑0017
Pet Licensing, Animal Bites, and Rabies: Rabies Vaccination for Animals 333‑019‑0019
Pet Licensing, Animal Bites, and Rabies: Dog Licensing 333‑019‑0022
Pet Licensing, Animal Bites, and Rabies: Wolf-Dog Hybrids 333‑019‑0024
Pet Licensing, Animal Bites, and Rabies: Management of Animal Bites 333‑019‑0027
Pet Licensing, Animal Bites, and Rabies: Management of Possibly Rabid Animals 333‑019‑0031
Other Disease Specific Provisions: Acquired Immunodeficiency Syndrome/Human Immunodeficiency Virus 333‑019‑0036
Other Disease Specific Provisions: Special Precautions Relating to Pregnancy and Childbirth 333‑019‑0039
Other Disease Specific Provisions: Sudden Infant Death Syndrome 333‑019‑0041
Other Disease Specific Provisions: Tuberculosis 333‑019‑0042
Other Disease Specific Provisions: Tuberculosis Screening in Correctional Facilities 333‑019‑0052
Other Disease Specific Provisions: Communication During Transfer of Patients with MDROs, C. difficile, or Any Organism Requiring Transmission-Based Precautions 333‑019‑0061
Infection Prevention in Health Care Settings
Last Updated

Jun. 8, 2021

Rule 333-019-0042’s source at or​.us